EP3083627
[1,2,4]Tríasóló[1,5-a]pýrimídínafleiður sem frumdýra-meltikorna-hindrar til meðhöndlunar á sníkilssjúkdómum eins og Leishmanssýki
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
18.12.2014EP published:
5.9.2018EP application number:
14825046.7
EP translation filed:
3.12.2018Grant published:
15.12.2018EPO information:
European Patent Register
Max expiry date:
17.12.2034Expiry date:
17.12.2023
Title:
[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AS PROTOZOAN PROTEASOME INHIBITORS FOR THE TREATMENT OF PARASITIC DISEASES SUCH AS LEISHMANIASIS
Timeline
Today
18.12.2014EP application
5.9.2018EP Publication
3.12.2018Translation submitted
15.12.2018Registration published
17.12.2023Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
BIGGART, AgnesAddress:
San Diego, California, US
Name:
LIANG, FangAddress:
San Diego, California, US
Name:
MATHISON, Casey Jacob NelsonAddress:
San Diego, California, US
Name:
MOLTENI, ValentinaAddress:
San Diego, California, US
Name:
NAGLE, Advait SureshAddress:
San Diego, California, US
Name:
SUPEK, FrantisekAddress:
San Diego, California, US
Name:
YEH, VinceAddress:
San Diego, California, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361918089 PDate:
19.12.2013Country:
US
Classification
Categories:
C07D 487/04, A61K 31/519, A61P 33/02
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 30.11.2018
Expires: 17.12.2019
Payer: Árnason Faktor
Number: 6
Paid: 26.11.2019
Expires: 17.12.2020
Payer: Árnason Faktor
Number: 7
Paid: 24.11.2020
Expires: 17.12.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 24.11.2021
Expires: 17.12.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 30.11.2022
Expires: 17.12.2023
Payer: Árnason Faktor ehf.